» Authors » Ladan Teimoori-Toolabi

Ladan Teimoori-Toolabi

Explore the profile of Ladan Teimoori-Toolabi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 543
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Gheidari F, Arefian E, Saadatpour F, Kabiri M, Seyedjafari E, Teimoori-Toolabi L, et al.
Mol Biol Rep . 2022 Oct; 49(12):11855-11866. PMID: 36219319
Background: Glioblastoma multiforme (GBM) is an aggressive and lethal brain cancer, which is incurable with standard cancer treatments. miRNAs have great potential to be used for gene therapy due to...
12.
Sheikholeslami S, Azizi F, Ghasemi A, Alibakhshi A, Parsa H, Shivaee S, et al.
Iran J Public Health . 2022 Jul; 51(3):634-642. PMID: 35865047
Background: Epigenetic alterations such as DNA methylation are known as the main cause of different types of cancers through inactivation of tumor suppressor genes, especially thyroid cancer. Identification of novel...
13.
Kiani-Zadeh M, Rezvany M, Namjoo S, Barati M, Mohammadi M, Ghasemi B, et al.
Mol Biol Rep . 2022 Jun; 49(8):7849-7862. PMID: 35733068
Hereby, we aimed to investigate the expression of prostaglandin-endoperoxide synthase 2 (PTGS2) and Vascular Endothelial Factor-C (VEGF-C) besides the methylation of PTGS2 in AML patients. VEGF-C and PTGS2 expression analysis...
14.
Shahbazi B, Arab S, Mafakher L, Azadmansh K, Teimoori-Toolabi L
J Biomol Struct Dyn . 2022 May; 41(10):4575-4591. PMID: 35510592
Pigment epithelium-derived factor (PEDF) is a member of the serine proteinase inhibitor (serpin) with antiangiogenic, anti-tumorigenic, antioxidant, anti-atherosclerosis, antithrombotic, anti-inflammatory, and neuroprotective properties. The PEDF can bind to low-density lipoprotein...
15.
Poorebrahim M, Abazari M, Moradi L, Shahbazi B, Mahmoudi R, Kalhor H, et al.
PLoS Comput Biol . 2022 Apr; 18(4):e1009962. PMID: 35472201
K-Ras activating mutations are significantly associated with tumor progression and aggressive metastatic behavior in various human cancers including pancreatic cancer. So far, despite a large number of concerted efforts, targeting...
16.
Shoushtari M, Mafakher L, Rahmati S, Salehi-Vaziri M, Arashkia A, Roohvand F, et al.
Mol Cell Probes . 2022 Apr; 63:101818. PMID: 35461964
One-third of the world's population is at risk of Dengue infection. Envelope domain 3 (EDIII) and nonstructural protein1 (NS1) proteins as the potent antigenicity regions for humoral immunity in addition...
17.
Alizadeh-Sedigh M, Mahmoodzadeh H, Fazeli M, Haddadi-Aghdam M, Teimoori-Toolabi L
Mol Cell Probes . 2022 Mar; 63:101807. PMID: 35296442
Background: Early diagnosis of colorectal cancer (CRC) can lead to prompt treatment modalities. Circulating cell-free DNA (cfDNA) analysis provides an alternative non-invasive procedure for the study of the molecular profiles...
18.
Shahbazi B, Mafakher L, Teimoori-Toolabi L
J Mol Model . 2022 Mar; 28(4):82. PMID: 35249180
Novel SARS coronavirus or SARS-CoV-2 is a novel coronavirus that was identified and spread from Wuhan in 2019. On January 30th, the World Health Organization declared the coronavirus outbreak as...
19.
Alizadeh-Sedigh M, Fazeli M, Mahmoodzadeh H, Sharif S, Teimoori-Toolabi L
Cancer Biomark . 2021 Dec; 34(2):221-250. PMID: 34957998
Background: Investigating aberrant tumor-specific methylation in plasma cell-free DNA provides a promising and noninvasive biomarker for cancer detection. Objective: We aimed to investigate methylation status of some promoter regions in...
20.
Sharifiaghdam M, Shaabani E, Sharifiaghdam Z, De Keersmaecker H, Lucas B, Lammens J, et al.
Nanoscale . 2021 Sep; 13(36):15445-15463. PMID: 34505619
Excessive inflammatory responses in wounds are characterized by the presence of high levels of pro-inflammatory M1 macrophages rather than pro-healing M2 macrophages, which leads to delayed wound healing. Macrophage reprogramming...